Psoriasis is a common inflammatory skin disease, but its pathogenesis is unknown. This paper presents 2 cases of psoriasis vulgaris in which the skin lesions were improved for 3 months and more after the start of oral treatment with 1α,25‐dihydroxyvitamin D3 at a dose of 0.5 μg/day. The circulating levels of calcium, inorganic phosphate, 25‐hydroxyvitamin D, 1α,25‐dihydroxyvitamin D, parathyroid hormone and calcitonin were within normal ranges before and after the start of treatment. These findings suggest that 1α,25‐dihydroxyvitamin D3 has a beneficial effect on psoriatic skin lesions. It probably has a direct effect on enhancing epidermal cell differentiation.
Abbreviations: Ca: calcium, hCT: calcitonin, 25‐OHD: 25‐hydroxyvitamin D, 1,25‐(OH)2D: 1α,25‐dihydroxyvitamin D, 1,25‐(OH)2D3: 1α,25‐dihydroxyvitamin D3, Pi: inorganic phosphate
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.